TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biogen Norway AS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
279,207
|
250,658
|
300,646 |
| Financial expenses |
1
|
15
|
245 |
| Earnings before taxes |
15,006
|
12,035
|
10,111 |
| Total assets |
226,816
|
208,037
|
209,747 |
| Current assets |
226,606
|
207,858
|
209,472 |
| Current liabilities |
47,218
|
37,109
|
36,726 |
| Equity capital |
179,598
|
170,928
|
173,020 |
| - share capital |
97
|
99
|
106 |
| Employees (average) |
9
|
19
|
26 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
79.2%
|
82.2%
|
82.5% |
| Turnover per employee |
31,023
|
13,193
|
11,563 |
| Profit as a percentage of turnover |
5.4%
|
4.8%
|
3.4% |
| Return on assets (ROA) |
6.6%
|
5.8%
|
4.9% |
| Current ratio |
479.9%
|
560.1%
|
570.4% |
| Return on equity (ROE) |
8.4%
|
7.0%
|
5.8% |
| Change turnover |
32,989
|
-30,068
|
-106,822 |
| Change turnover % |
13%
|
-11%
|
-26% |
| Chg. No. of employees |
-10
|
-7
|
7 |
| Chg. No. of employees % |
-53%
|
-27%
|
37% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.